Available 0 9 0 9 O
for 10 13 10 13 O
the 14 17 14 17 O
duration 18 26 18 26 O
of 27 29 27 29 O
the 30 33 30 33 O
trial 34 39 34 39 O
( 40 41 40 41 O
6 41 42 41 42 B-upper_bound
months 43 49 43 49 I-upper_bound
) 49 50 49 50 O

Currently 0 9 51 60 O
lactating 10 19 61 70 O
and 20 23 71 74 O
breast 24 30 75 81 O
- 30 31 81 82 O
feeding 31 38 82 89 O
( 39 40 90 91 O
if 40 42 91 93 O
female 43 49 94 100 B-gender
) 49 50 100 101 O

Evidence 0 8 102 110 O
of 9 11 111 113 O
clinically 12 22 114 124 O
significant 23 34 125 136 O
neurologic 35 45 137 147 B-chronic_disease
, 45 46 147 148 O
cardiac 47 54 149 156 B-chronic_disease
, 54 55 156 157 O
pulmonary 56 65 158 167 B-chronic_disease
, 65 66 167 168 O
hepatic 67 74 169 176 B-chronic_disease
, 74 75 176 177 O
rheumatologic 76 89 178 191 B-chronic_disease
, 89 90 191 192 O
autoimmune 91 101 193 203 B-chronic_disease
, 101 102 203 204 O
diabetes 103 111 205 213 B-chronic_disease
, 111 112 213 214 O
or 113 115 215 217 O
renal 116 121 218 223 B-chronic_disease
disease 122 129 224 231 I-chronic_disease
by 130 132 232 234 O
history 133 140 235 242 O
, 140 141 242 243 O
physical 142 150 244 252 O
examination 151 162 253 264 O
, 162 163 264 265 O
and/or 164 170 266 272 O
laboratory 171 181 273 283 O
studies 182 189 284 291 O

History 0 7 292 299 O
of 8 10 300 302 O
a 11 12 303 304 O
severe 13 19 305 311 B-chronic_disease
allergic 20 28 312 320 I-chronic_disease
reaction 29 37 321 329 I-chronic_disease
or 38 40 330 332 O
anaphylaxis 41 52 333 344 B-chronic_disease

History 0 7 345 352 O
of 8 10 353 355 O
hypoalbuminemia 11 26 356 371 B-chronic_disease

History 0 7 372 379 O
of 8 10 380 382 O
iron 11 15 383 387 B-chronic_disease
deficiency 16 26 388 398 I-chronic_disease
anemia 27 33 399 405 I-chronic_disease

History 0 7 406 413 O
of 8 10 414 416 O
previous 11 19 417 425 O
infection 20 29 426 435 B-chronic_disease
with 30 34 436 440 O
hookworm 35 43 441 449 O
or 44 46 450 452 O
residence 47 56 453 462 O
for 57 60 463 466 O
more 61 65 467 471 O
than 66 70 472 476 O
6 71 72 477 478 B-lower_bound
months 73 79 479 485 I-lower_bound
in 80 82 486 488 O
a 83 84 489 490 O
hookworm 85 93 491 499 O
- 93 94 499 500 O
endemic 94 101 500 507 O
area 102 106 508 512 O

Known 0 5 513 518 O
allergy 6 13 519 526 O
to 14 16 527 529 O
amphotericin 17 29 530 542 B-allergy_name
B 30 31 543 544 I-allergy_name
or 32 34 545 547 O
gentamicin 35 45 548 558 B-allergy_name

Known 0 5 559 564 O
or 6 8 565 567 O
suspected 9 18 568 577 O
immunodeficiency 19 35 578 594 B-chronic_disease

Laboratory 0 10 595 605 O
evidence 11 19 606 614 O
of 20 22 615 617 O
a 23 24 618 619 O
coagulopathy 25 37 620 632 B-chronic_disease
( 38 39 633 634 O
PTT 39 42 634 637 B-clinical_variable
or 43 45 638 640 O
PT 46 48 641 643 O
INR 49 52 644 647 B-clinical_variable
greater 53 60 648 655 O
than 61 65 656 660 O
1.1 66 69 661 664 B-lower_bound
- 69 70 664 665 I-lower_bound
times 70 75 665 670 I-lower_bound
the 76 79 671 674 I-lower_bound
upper 80 85 675 680 I-lower_bound
reference 86 95 681 690 I-lower_bound
limit 96 101 691 696 I-lower_bound
) 101 102 696 697 O

Laboratory 0 10 698 708 O
evidence 11 19 709 717 O
of 20 22 718 720 O
hematologic 23 34 721 732 B-chronic_disease
disease 35 42 733 740 I-chronic_disease
( 43 44 741 742 O
hemoglobin 44 54 742 752 B-clinical_variable
< 55 56 753 754 O
11.5 56 60 754 758 B-upper_bound
g 61 62 759 760 I-upper_bound
/ 62 63 760 761 I-upper_bound
dl 63 65 761 763 I-upper_bound
[ 66 67 764 765 O
females 67 74 765 772 B-gender
] 74 75 772 773 O
or 76 78 774 776 O
< 79 80 777 778 O
12.5 80 84 778 782 B-upper_bound
g 85 86 783 784 I-upper_bound
/ 86 87 784 785 I-upper_bound
dl 87 89 785 787 I-upper_bound
[ 90 91 788 789 O
males 91 96 789 794 O
] 96 97 794 795 O
; 97 98 795 796 O
absolute 99 107 797 805 B-clinical_variable
leukocyte 108 117 806 815 I-clinical_variable
count 118 123 816 821 I-clinical_variable
< 124 125 822 823 O
3.6 125 128 823 826 B-upper_bound
or 129 131 827 829 O
> 132 133 830 831 O
10.7 133 137 831 835 B-lower_bound
x 138 139 836 837 I-lower_bound
103 140 143 838 841 I-lower_bound
/ 143 144 841 842 I-lower_bound
mm3 144 147 842 845 I-lower_bound
; 147 148 845 846 O
absolute 149 157 847 855 B-clinical_variable
neutrophil 158 168 856 866 I-clinical_variable
count 169 174 867 872 I-clinical_variable
[ 175 176 873 874 I-clinical_variable
ANC 176 179 874 877 I-clinical_variable
] 179 180 877 878 I-clinical_variable
< 181 182 879 880 O
1.7 182 185 880 883 B-upper_bound
x 186 187 884 885 I-upper_bound
103 188 191 886 889 I-upper_bound
/ 191 192 889 890 I-upper_bound
mm3 192 195 890 893 I-upper_bound
; 195 196 893 894 O
absolute 197 205 895 903 B-clinical_variable
lymphocyte 206 216 904 914 I-clinical_variable
count 217 222 915 920 I-clinical_variable
< 223 224 921 922 O
0.7 224 227 922 925 O
x 228 229 926 927 O
103 230 233 928 931 O
/ 233 234 931 932 O
mm3 234 237 932 935 O
; 237 238 935 936 O
or 239 241 937 939 O
platelet 242 250 940 948 B-clinical_variable
count 251 256 949 954 I-clinical_variable
< 257 258 955 956 O
140 258 261 956 959 B-upper_bound
x 262 263 960 961 I-upper_bound
103 264 267 962 965 I-upper_bound
/ 267 268 965 966 I-upper_bound
mm3 268 271 966 969 I-upper_bound
) 271 272 969 970 O

Laboratory 0 10 971 981 O
evidence 11 19 982 990 O
of 20 22 991 993 O
liver 23 28 994 999 B-chronic_disease
disease 29 36 1000 1007 I-chronic_disease
( 37 38 1008 1009 O
alanine 38 45 1009 1016 B-clinical_variable
aminotransferase 46 62 1017 1033 I-clinical_variable
[ 63 64 1034 1035 I-clinical_variable
ALT 64 67 1035 1038 I-clinical_variable
] 67 68 1038 1039 I-clinical_variable
greater 69 76 1040 1047 O
than 77 81 1048 1052 O
1.25 82 86 1053 1057 B-lower_bound
- 86 87 1057 1058 I-lower_bound
times 87 92 1058 1063 I-lower_bound
the 93 96 1064 1067 I-lower_bound
upper 97 102 1068 1073 I-lower_bound
reference 103 112 1074 1083 I-lower_bound
limit 113 118 1084 1089 I-lower_bound
) 118 119 1089 1090 O

Laboratory 0 10 1091 1101 O
evidence 11 19 1102 1110 O
of 20 22 1111 1113 O
renal 23 28 1114 1119 B-chronic_disease
disease 29 36 1120 1127 I-chronic_disease
( 37 38 1128 1129 O
serum 38 43 1129 1134 O
creatinine 44 54 1135 1145 B-clinical_variable
greater 55 62 1146 1153 O
than 63 67 1154 1158 O
1.25 68 72 1159 1163 B-lower_bound
- 72 73 1163 1164 I-lower_bound
times 73 78 1164 1169 I-lower_bound
the 79 82 1170 1173 O
upper 83 88 1174 1179 B-clinical_variable
reference 89 98 1180 1189 I-clinical_variable
limit 99 104 1190 1195 I-clinical_variable
, 104 105 1195 1196 O
or 106 108 1197 1199 O
more 109 113 1200 1204 O
than 114 118 1205 1209 O
trace 119 124 1210 1215 O
protein 125 132 1216 1223 O
or 133 135 1224 1226 O
blood 136 141 1227 1232 O
on 142 144 1233 1235 O
urine 145 150 1236 1241 O
dipstick 151 159 1242 1250 O
testing 160 167 1251 1258 O
) 167 168 1258 1259 O

Males 0 5 1260 1265 B-gender

Participant 0 11 1266 1277 O
unwilling 12 21 1278 1287 B-contraception_consent
to 22 24 1288 1290 I-contraception_consent
use 25 28 1291 1294 I-contraception_consent
reliable 29 37 1295 1303 I-contraception_consent
contraception 38 51 1304 1317 I-contraception_consent
methods 52 59 1318 1325 I-contraception_consent
while 60 65 1326 1331 O
participating 66 79 1332 1345 O
in 80 82 1346 1348 O
the 83 86 1349 1352 O
study 87 92 1353 1358 O
( 93 94 1359 1360 O
if 94 96 1360 1362 O
female 97 103 1363 1369 B-gender
and 104 107 1370 1373 O
not 108 111 1374 1377 O
surgically 112 122 1378 1388 B-treatment
sterile 123 130 1389 1396 I-treatment
, 130 131 1396 1397 O
abstinent 132 141 1398 1407 O
or 142 144 1408 1410 O
at 145 147 1411 1413 O
least 148 153 1414 1419 O
2 154 155 1420 1421 B-lower_bound
years 156 161 1422 1427 I-lower_bound
post 162 166 1428 1432 O
- 166 167 1432 1433 O
menopausal 167 177 1433 1443 O
) 177 178 1443 1444 O

Positive 0 8 1445 1453 O
ELISA 9 14 1454 1459 B-treatment
for 15 18 1460 1463 O
hepatitis 19 28 1464 1473 B-chronic_disease
B 29 30 1474 1475 I-chronic_disease
surface 31 38 1476 1483 O
antigen 39 46 1484 1491 O
( 47 48 1492 1493 O
HBsAg 48 53 1493 1498 O
) 53 54 1498 1499 O

Positive 0 8 1500 1508 O
confirmatory 9 21 1509 1521 O
test 22 26 1522 1526 O
for 27 30 1527 1530 O
HIV 31 34 1531 1534 B-chronic_disease
infection 35 44 1535 1544 I-chronic_disease

Positive 0 8 1545 1553 O
confirmatory 9 21 1554 1566 O
test 22 26 1567 1571 O
for 27 30 1572 1575 O
hepatitis 31 40 1576 1585 B-chronic_disease
C 41 42 1586 1587 I-chronic_disease
virus 43 48 1588 1593 I-chronic_disease
( 49 50 1594 1595 I-chronic_disease
HCV 50 53 1595 1598 I-chronic_disease
) 53 54 1598 1599 I-chronic_disease
infection 55 64 1600 1609 I-chronic_disease

Pregnancy 0 9 1610 1619 B-pregnancy
as 10 12 1620 1622 O
determined 13 23 1623 1633 O
by 24 26 1634 1636 O
a 27 28 1637 1638 O
positive 29 37 1639 1647 O
urine 38 43 1648 1653 B-treatment
human 44 49 1654 1659 I-treatment
choriogonadotropin 50 68 1660 1678 I-treatment
( 69 70 1679 1680 I-treatment
hCG 70 73 1680 1683 I-treatment
) 73 74 1683 1684 I-treatment
( 75 76 1685 1686 O
if 76 78 1686 1688 O
female 79 85 1689 1695 B-gender
) 85 86 1695 1696 O

Receipt 0 7 1697 1704 O
of 8 10 1705 1707 O
a 11 12 1708 1709 O
live 13 17 1710 1714 B-treatment
vaccine 18 25 1715 1722 I-treatment
within 26 32 1723 1729 O
4 33 34 1730 1731 B-upper_bound
weeks 35 40 1732 1737 I-upper_bound
or 41 43 1738 1740 O
a 44 45 1741 1742 O
killed 46 52 1743 1749 O
vaccine 53 60 1750 1757 O
within 61 67 1758 1764 O
2 68 69 1765 1766 B-treatment
weeks 70 75 1767 1772 I-treatment
prior 76 81 1773 1778 I-treatment
to 82 84 1779 1781 O
the 85 88 1782 1785 O
volunteer 89 98 1786 1795 O
's 98 100 1795 1797 O
expected 101 109 1798 1806 O
Day 110 113 1807 1810 O
0 114 115 1811 1812 O
of 116 118 1813 1815 O
the 119 122 1816 1819 O
study 123 128 1820 1825 O

Receipt 0 7 1826 1833 O
of 8 10 1834 1836 O
blood 11 16 1837 1842 O
products 17 25 1843 1851 O
within 26 32 1852 1858 O
the 33 36 1859 1862 O
past 37 41 1863 1867 B-upper_bound
6 42 43 1868 1869 I-upper_bound
months 44 50 1870 1876 I-upper_bound

Serum 0 5 1877 1882 B-clinical_variable
glucose 6 13 1883 1890 I-clinical_variable
( 14 15 1891 1892 O
random 15 21 1892 1898 O
) 21 22 1898 1899 O
greater 23 30 1900 1907 O
than 31 35 1908 1912 O
1.2 36 39 1913 1916 B-lower_bound
- 39 40 1916 1917 I-lower_bound
times 40 45 1917 1922 I-lower_bound
the 46 49 1923 1926 I-lower_bound
upper 50 55 1927 1932 I-lower_bound
reference 56 65 1933 1942 I-lower_bound
limit 66 71 1943 1948 I-lower_bound

Severe 0 6 1949 1955 B-chronic_disease
asthma 7 13 1956 1962 I-chronic_disease
as 14 16 1963 1965 O
defined 17 24 1966 1973 O
by 25 27 1974 1976 O
the 28 31 1977 1980 O
need 32 36 1981 1985 O
for 37 40 1986 1989 O
daily 41 46 1990 1995 O
use 47 50 1996 1999 O
of 51 53 2000 2002 O
inhalers 54 62 2003 2011 O
or 63 65 2012 2014 O
emergency 66 75 2015 2024 O
clinic 76 82 2025 2031 O
visit 83 88 2032 2037 O
or 89 91 2038 2040 O
hospitalization 92 107 2041 2056 O
within 108 114 2057 2063 O
6 115 116 2064 2065 B-upper_bound
months 117 123 2066 2072 I-upper_bound
of 124 126 2073 2075 O
the 127 130 2076 2079 O
volunteer 131 140 2080 2089 O
's 140 142 2089 2091 O
expected 143 151 2092 2100 O
Day 152 155 2101 2104 O
0 156 157 2105 2106 O
of 158 160 2107 2109 O
the 161 164 2110 2113 O
study 165 170 2114 2119 O

Use 0 3 2120 2123 O
of 4 6 2124 2126 O
corticosteroids 7 22 2127 2142 B-treatment
( 23 24 2143 2144 O
excluding 24 33 2144 2153 O
topical 34 41 2154 2161 O
or 42 44 2162 2164 O
nasal 45 50 2165 2170 O
) 50 51 2170 2171 O
or 52 54 2172 2174 O
immunosuppressive 55 72 2175 2192 B-treatment
drugs 73 78 2193 2198 I-treatment
within 79 85 2199 2205 O
30 86 88 2206 2208 B-upper_bound
days 89 93 2209 2213 I-upper_bound
of 94 96 2214 2216 O
the 97 100 2217 2220 O
volunteer 101 110 2221 2230 O
's 110 112 2230 2232 O
expected 113 121 2233 2241 O
Day 122 125 2242 2245 O
0 126 127 2246 2247 O
of 128 130 2248 2250 O
this 131 135 2251 2255 O
study 136 141 2256 2261 O
or 142 144 2262 2264 O
planned 145 152 2265 2272 O
use 153 156 2273 2276 O
during 157 163 2277 2283 O
the 164 167 2284 2287 O
study 168 173 2288 2293 O

Volunteer 0 9 2294 2303 O
has 10 13 2304 2307 O
had 14 17 2308 2311 O
medical 18 25 2312 2319 O
, 25 26 2319 2320 O
occupational 27 39 2321 2333 O
, 39 40 2333 2334 O
or 41 43 2335 2337 O
family 44 50 2338 2344 O
problems 51 59 2345 2353 O
as 60 62 2354 2356 O
a 63 64 2357 2358 O
result 65 71 2359 2365 O
of 72 74 2366 2368 O
alcohol 75 82 2369 2376 O
or 83 85 2377 2379 O
illicit 86 93 2380 2387 O
drug 94 98 2388 2392 O
use 99 102 2393 2396 O
during 103 109 2397 2403 O
the 110 113 2404 2407 O
past 114 118 2408 2412 B-upper_bound
12 119 121 2413 2415 I-upper_bound
months 122 128 2416 2422 I-upper_bound

between 0 7 2423 2430 O
18 8 10 2431 2433 B-lower_bound
and 11 14 2434 2437 O
45 15 17 2438 2440 B-upper_bound
years 18 23 2441 2446 I-upper_bound
, 23 24 2446 2447 O
inclusive 25 34 2448 2457 O

females 0 7 2458 2465 B-gender

